All practice questions

8270 questions

Question 2341Question →

An infectious diseases consultation is requested for a 5959-year-old male inpatient. He was admitted 44 days ago with severe back pain and fever, leading to a diagnosis of T10−T11\text{T10}-\text{T11} vertebral osteomyelitis and an associated epidural abscess. Urgent surgical decompression and debridement were performed on the day of admission. Blood cultures obtained prior to antibiotic administration, as well as intraoperative tissue specimens, have both grown Staphylococcus aureus. Susceptibility testing confirms the isolate is susceptible to oxacillin, cefazolin, vancomycin, and daptomycin. The patient has been receiving empiric intravenous vancomycin therapy since presentation. His medical history includes type 22 diabetes mellitus and hypertension. 33 years ago, he experienced a severe allergic reaction following a dose of oral amoxicillin; he rapidly developed diffuse urticaria, wheezing, and facial angioedema, which necessitated emergency administration of intramuscular epinephrine. He has no prior exposure to cephalosporin antibiotics. Currently, his vital signs are stable, and his serum creatinine is 0.9 mg/dL0.9 \text{ mg/dL}. Based on current guidelines, which of the following is the most appropriate next step in the pharmacologic management of this infection?

Show answer & explanation

Answer: Discontinue vancomycin and start intravenous cefazolin

Answer

The most appropriate next step is to discontinue vancomycin and start intravenous cefazolin.
The correct answer is to switch the patient to intravenous cefazolin. This patient has a severe infection caused by methicillin-susceptible Staphylococcus aureus (MSSA). For MSSA infections, anti-staphylococcal beta-lactams (such as cefazolin) are significantly superior to vancomycin, demonstrating faster clearance of bacteremia, lower rates of clinical failure, and reduced mortality. Although this patient has a history of IgE-mediated anaphylaxis to amoxicillin (a penicillin), cefazolin is remarkably safe to administer. Cross-reactivity between penicillins and cephalosporins is not caused by the core beta-lactam ring itself, but rather by similarities in the R1 side chains. Cefazolin possesses a unique R1 side chain that is structurally distinct from all penicillins and almost all other cephalosporins. Therefore, it does not cross-react with penicillins, and current infectious disease and allergy guidelines strongly recommend the direct administration of cefazolin for MSSA infections in patients with penicillin anaphylaxis, without the need for prior skin testing or desensitization.

Step-by-Step Solution

1
Identify the pathogen and determine the optimal class of antibiotics for targeted therapy.
The patient has a severe, deep-seated infection (osteomyelitis and epidural abscess) caused by Methicillin-susceptible Staphylococcus aureus (MSSA).
For invasive MSSA infections, anti-staphylococcal beta-lactams (e.g., cefazolin, nafcillin, oxacillin) are the gold standard, as they provide vastly superior bactericidal activity compared to vancomycin, resulting in lower clinical failure and mortality rates.
2
Assess the impact of the patient's severe amoxicillin allergy on beta-lactam selection.
The patient had an IgE-mediated anaphylactic reaction to amoxicillin. Therefore, all penicillins (including oxacillin and nafcillin) are strictly contraindicated due to shared structural determinants.
Amoxicillin and oxacillin share the core penicillin beta-lactam structure, posing an unacceptably high risk of a recurrent life-threatening allergic reaction.
3
Evaluate the safety profile of cefazolin in the context of penicillin anaphylaxis.
Cefazolin can be safely administered to this patient despite the history of amoxicillin anaphylaxis.
Cross-reactivity between penicillins and cephalosporins is driven almost entirely by structural similarities in the R1 side chains, not the beta-lactam ring itself. Cefazolin possesses a completely unique R1 side chain that does not cross-react with penicillins or amoxicillin. Current guidelines recommend direct administration of cefazolin without prior testing in this scenario.

Key Concept

Patients with severe MSSA infections should be treated with an anti-staphylococcal beta-lactam rather than vancomycin to improve survival. Cefazolin possesses a unique R1 side chain and does not cross-react with penicillins, making it the preferred and safe definitive therapy even in patients with a history of severe, IgE-mediated anaphylaxis to penicillins.
Question 2342Question →

A 68-year-old woman is evaluated in the hospital for new-onset skin lesions. Six days ago, she was admitted for a right lower extremity deep vein thrombosis and started on a continuous intravenous unfractionated heparin infusion and oral warfarin. Two days ago, her platelet count was noted to have decreased from 260,000/mm3260,000/\text{mm}^3 on admission to 105,000/mm3105,000/\text{mm}^3. Heparin was immediately discontinued, a serotonin release assay was sent, and an intravenous argatroban infusion was started. Warfarin was continued. Today, she complains of significant pain over her abdomen and both thighs. Physical examination reveals well-demarcated, erythematous, and purpuric lesions with central areas of black necrosis in these regions. Vital signs are stable.

Laboratory results today:
Hemoglobin: 11.2 g/dL11.2\text{ g/dL}
Platelet count: 110,000/mm3110,000/\text{mm}^3
Prothrombin time (PT): 25 sec25\text{ sec}
Activated partial thromboplastin time (aPTT): 68 sec68\text{ sec}
INR: 2.42.4

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue warfarin and administer intravenous vitamin K

Answer

Discontinue warfarin and administer intravenous vitamin K
This patient's clinical presentation—well-demarcated, purpuric lesions progressing to black necrosis on the abdomen and thighs—is classic for warfarin-induced skin necrosis. This rare but serious complication typically occurs 3 to 5 days after initiating warfarin. It results from the rapid depletion of protein C, a vitamin K-dependent natural anticoagulant with a short half-life (approximately 8 hours), which declines significantly faster than the procoagulant factors II, IX, and X. This mismatch creates a transient, severe hypercoagulable state leading to microvascular thrombosis in subcutaneous fat. The risk is significantly magnified in patients with an underlying hypercoagulable state, particularly heparin-induced thrombocytopenia (HIT). In patients with HIT, warfarin is strictly contraindicated until the platelet count has fully recovered (typically >150,000/mm3150,000/\text{mm}^3) because the combination of HIT-associated thrombosis and warfarin-induced protein C depletion can lead to catastrophic venous limb gangrene or skin necrosis. The most appropriate next step is to immediately discontinue the offending agent (warfarin), administer intravenous vitamin K to replenish protein C and reverse the hypercoagulable state, and continue a non-heparin anticoagulant (such as argatroban) to treat the underlying HIT and DVT.

Step-by-Step Solution

1
Analyze the patient's primary diagnosis based on the initial presentation and hospital course.
The patient developed a drop in platelets (>50%) after starting heparin, which is highly suspicious for heparin-induced thrombocytopenia (HIT). This was appropriately treated by stopping heparin and starting argatroban.
Establishing the underlying hypercoagulable state is crucial for understanding subsequent complications.
2
Evaluate the new-onset skin findings in the context of her medications.
The patient developed purpuric, necrotic skin lesions on her abdomen and thighs on day 6 of warfarin therapy. This is the classic presentation of warfarin-induced skin necrosis.
Identifying the etiology of the skin lesions determines the appropriate life-saving intervention.
3
Determine the optimal management for warfarin-induced skin necrosis in a patient with HIT.
Warfarin must be discontinued immediately. Intravenous vitamin K is administered to rapidly reverse the transient protein C depletion, while argatroban is continued to manage the HIT and underlying DVT.
Removing the offending agent and reversing its mechanism is the definitive treatment, while continuous non-heparin anticoagulation prevents systemic thrombosis.

Key Concept

Warfarin-induced skin necrosis in Heparin-Induced Thrombocytopenia (HIT)
Question 2343Question →

A 4-year-old girl is brought to the office by her father for a well-child examination. The father is worried about her overall development. He states that since she started attending a new preschool three months ago, she has frequently engaged in conversations with an "imaginary friend" in her bedroom. Furthermore, she intermittently repeats syllables when she is very eager to talk about her day. The father is also concerned because she is unable to draw a square or ride a two-wheeled bicycle, milestones that her older sibling had already achieved by age 5. Her medical history is unremarkable. On examination, the patient appears well-nourished and cooperative. She is able to hop on one foot and catch a bounced ball. When given paper and crayons, she successfully draws a person with four body parts and copies a cross, but she cannot draw a square or a triangle. During the visit, her speech is entirely understandable to the physician, and she exhibits no facial grimacing, jaw jerking, or eye blinking when repeating syllables. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance that her development is age-appropriate

Answer

Reassurance that her development is age-appropriate
The patient's presentation represents perfectly normal development for a 4-year-old child. At 4 years of age, normal motor milestones include hopping on one foot, catching a bounced ball, drawing a person with at least three body parts, and copying a cross. Copying a square, copying a triangle, and riding a two-wheeled bicycle are typical 5-year-old milestones, making it entirely normal that this 4-year-old cannot do them yet. Additionally, 100% speech intelligibility is expected by age 4, which she demonstrates. Developmental dysfluency—stuttering without secondary features like tics, eye blinking, or grimacing—is very common in preschool children, often occurs when they are excited, and typically self-resolves. Finally, imaginary companions are a healthy aspect of normal socioemotional development in children aged 3 to 6 years. Because all of these findings are benign, reassurance is the only appropriate intervention.

Step-by-Step Solution

1
Evaluate the patient's fine and gross motor development against age-based milestones.
The patient can draw a person with four parts, copy a cross, hop on one foot, and catch a bounced ball.
These findings represent expected 4-year-old milestones. Copying a square and riding a two-wheeled bicycle are 5-year-old milestones, explaining her inability to perform them yet.
2
Assess the patient's language development and the father's concern about stuttering.
Her speech is 100% intelligible with periods of dysfluency but no secondary behaviors like grimacing.
By age 4, a child's speech should be entirely understandable to strangers. Developmental dysfluency without secondary physical features is a normal variant that typically resolves spontaneously.
3
Analyze the significance of the patient's imaginary friend.
The presence of an imaginary friend in a 4-year-old child is identified as a normal behavioral finding.
Imaginary companions are a healthy part of socioemotional development in preschool-aged children and aid in creative processing.
4
Determine the next best step in management.
Since all findings are normal variants or age-appropriate, no specialized testing or therapy is needed.
Unnecessary referrals can cause undue parental anxiety and medicalize normal childhood development.

Key Concept

Normal developmental milestones in a 4-year-old include 100% speech intelligibility, hopping on one foot, copying a cross, and drawing a person with four body parts. Imaginary friends and developmental dysfluency (stuttering without secondary physical behaviors) are common normal variants at this age.
Estimated Time:1m 0s
Question 2344Question →

Match each pediatric patient presenting for a routine well-child visit with the corresponding age-appropriate universal screening test recommended by the American Academy of Pediatrics.

Click a left item, then click its matching right item

Items

A 12-month-old asymptomatic boy with no significant medical or family history
An 18-month-old asymptomatic girl with typical development and growth
A 4-year-old asymptomatic boy preparing to start a preschool program
A 10-year-old asymptomatic girl with an active lifestyle
A 12-year-old asymptomatic boy attending the clinic for an annual physical examination

Matches

Show answer & explanation

Answer

The 12-month-old matches with hemoglobin measurement. The 18-month-old matches with the autism screening tool. The 4-year-old matches with objective visual acuity testing. The 10-year-old matches with a lipid profile. The 12-year-old matches with the standardized depression screening questionnaire.
The correct matches align with the American Academy of Pediatrics (AAP) periodicity schedule for universal screening. At 12 months, infants are universally screened for anemia. At 18 months, toddlers receive their first formal autism spectrum disorder screening. At 4 years, children are cognitively mature enough for objective visual acuity testing using a chart. Between ages 9 and 11 (e.g., 10 years old), children undergo universal dyslipidemia screening. At 12 years, universal depression screening begins for adolescents.

Step-by-Step Solution

1
Identify the purpose of the clinical encounter.
Each scenario describes a routine health maintenance examination for an asymptomatic pediatric patient at a specific age milestone.
This establishes that universal screening guidelines, rather than targeted risk-based guidelines, apply.
2
Recall the American Academy of Pediatrics (AAP) Bright Futures periodicity schedule.
Identify the specific universal screening tests uniquely introduced or emphasized at 12 months, 18 months, 4 years, 10 years, and 12 years.
Matching age milestones to screening protocols is a core competency in pediatric preventive care.
3
Pair each patient profile with the correct intervention.
12 months to anemia screening, 18 months to autism screening, 4 years to vision testing, 10 years to lipid screening, and 12 years to depression screening.
This completes the matching requirement based on established pediatric guidelines.

Key Concept

Universal Pediatric Screening Guidelines (AAP Bright Futures periodicity schedule)
Question 2345Question →

A pediatric clinic is reviewing its protocols for routine health maintenance and immunization delivery. The clinical educator asks the medical students to outline the chronological progression of vaccinations. Arrange the following immunization milestones in chronological order based on the age at which they are routinely indicated for a healthy, full-term child in the United States, starting from the earliest intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence begins with the standalone Hepatitis B vaccine at birth, followed by the initial DTaP/IPV/Hib/PCV/rotavirus series at 2 months, the introduction of MMR and varicella at 12 months, the preschool boosters at 4 to 6 years, and finally the adolescent Tdap/MenACWY/HPV platform at 11 to 12 years.
The sequence directly follows the CDC immunization schedule. The Hepatitis B vaccine is given at birth. The core inactivated infant series (plus oral rotavirus) begins at 2 months. Subcutaneous live vaccines (MMR, varicella) are withheld until 12 months to avoid maternal antibody interference. A major booster combination (DTaP, IPV, MMR, varicella) is given at 4 to 6 years before school entry. Finally, the adolescent platform (Tdap, MenACWY, HPV) is administered at 11 to 12 years.

Step-by-Step Solution

1
Identify the recommended age for the standalone Hepatitis B vaccination.
Birth (within 24 hours).
This is the only vaccine routinely administered in the newborn nursery to prevent vertical transmission.
2
Identify the recommended age for the initial DTaP, IPV, Hib, pneumococcal conjugate, and rotavirus series.
2 months of age.
The primary series for these core infant vaccines universally begins at the 2-month well-child visit.
3
Identify the recommended age for the first doses of subcutaneous live-attenuated vaccines (MMR and varicella).
12 to 15 months of age.
Administration is delayed until at least 12 months of age to prevent interference from passive maternal antibodies.
4
Identify the recommended age for the preschool boosters of DTaP, IPV, MMR, and varicella.
4 to 6 years of age.
These boosters are required to maintain immunity prior to the increased exposure risk of entering school.
5
Identify the recommended age for the adolescent vaccine platform (Tdap, MenACWY, HPV).
11 to 12 years of age.
This cluster of vaccines is specifically designed to provide protection against diseases with increased risk during adolescence and adulthood.
6
Sequence the interventions chronologically.
Birth -> 2 months -> 12-15 months -> 4-6 years -> 11-12 years.
This outlines the standard trajectory of the pediatric immunization schedule.

Key Concept

The CDC Recommended Child and Adolescent Immunization Schedule outlines a highly specific, age-based timeline for the introduction and boosting of vaccines to maximize immunogenicity and prevent disease outbreaks.
Question 2346Question →

Match the following clinical scenarios of patients presenting with thrombocytopenia to the most likely underlying diagnosis.

Click a left item, then click its matching right item

Items

A 32-year-old woman presents with petechiae and mucosal bleeding. Laboratory studies show a platelet count of 18,000/μL18,000/\mu L. Prothrombin time, activated partial thromboplastin time, and peripheral blood smear are unremarkable.
A 45-year-old man presents with fever, acute confusion, and a new-onset seizure. Labs reveal a platelet count of 24,000/μL24,000/\mu L, hemoglobin of 8.2 g/dL8.2 \text{ g/dL}, and serum creatinine of 2.5 mg/dL2.5 \text{ mg/dL}. A peripheral smear shows numerous schistocytes.
A 65-year-old woman recovering from a total knee arthroplasty develops a swollen, painful right calf on postoperative day 6. Her platelet count has decreased from 210,000/μL210,000/\mu L on admission to 95,000/μL95,000/\mu L today.
A 29-year-old woman at 36 weeks gestation develops abruptio placentae and severe postpartum hemorrhage. Labs show a platelet count of 45,000/μL45,000/\mu L, prolonged prothrombin time, prolonged activated partial thromboplastin time, and elevated D-dimer.

Matches

Show answer & explanation

Answer

The correct matches are based on specific laboratory and clinical signatures: Scenario 1 represents Immune thrombocytopenia (ITP); Scenario 2 represents Thrombotic thrombocytopenic purpura (TTP); Scenario 3 represents Heparin-induced thrombocytopenia (HIT); and Scenario 4 represents Disseminated intravascular coagulation (DIC).
Each thrombocytopenic disorder has a distinct clinical and laboratory signature. ITP is a diagnosis of exclusion characterized by isolated thrombocytopenia. TTP presents with microangiopathic hemolytic anemia and end-organ damage due to ADAMTS13 deficiency. HIT presents with a paradoxical prothrombotic state 5-10 days after heparin exposure due to antibodies against the heparin-PF4 complex. DIC involves systemic activation of coagulation and consumption of factors, leading to prolonged PT/aPTT and elevated fibrin split products.

Step-by-Step Solution

1
Analyze the first scenario for isolated lab abnormalities.
The patient has severe thrombocytopenia but normal PT, aPTT, and peripheral smear.
Ruling out consumptive coagulopathy and microangiopathic processes points to peripheral platelet destruction (ITP).
2
Evaluate the second scenario for the classic TTP pentad.
The patient exhibits fever, neurologic symptoms, thrombocytopenia, renal failure, and schistocytes.
This combination of microangiopathic hemolytic anemia and multiorgan involvement is diagnostic for TTP.
3
Examine the third scenario for temporal clues and paradoxical findings.
The patient has a 50% platelet drop 6 days post-surgery with a new prothrombotic event (DVT).
Post-surgical patients receive heparin prophylaxis; the specific timeline and paradoxical thrombosis identify HIT.
4
Assess the fourth scenario for broad coagulation system failure.
The patient has an obstetric trigger (abruption) followed by bleeding, low platelets, prolonged PT/aPTT, and elevated D-dimer.
Widespread factor consumption and fibrinolysis confirm DIC.

Key Concept

Differential diagnosis of thrombocytopenia based on clinical presentation, coagulation panels, and peripheral blood smear findings.
Question 2347Question →

Match the following classic infectious disease clinical presentations with the most appropriate first-line antimicrobial therapy.

Click a left item, then click its matching right item

Items

A 20-year-old college student with fever, neck stiffness, and cerebrospinal fluid analysis revealing gram-negative diplococci.
A 30-year-old pregnant woman in her first trimester who presents with an expanding targetoid rash (erythema migrans) after a tick bite.
A 45-year-old man with an indurated, painless ulcer on his penis and bilateral inguinal lymphadenopathy.
A 25-year-old woman with dysuria, increased urinary frequency, and a positive nitrite test on urinalysis, with no fever or flank pain.

Matches

Show answer & explanation

Answer

Gram-negative diplococci (meningitis) pairs with IV ceftriaxone. Lyme disease in pregnancy pairs with oral amoxicillin. Primary syphilis pairs with IM penicillin G benzathine. Uncomplicated cystitis pairs with oral nitrofurantoin.
Each clinical scenario presents a classic infectious disease that requires a specific first-line antimicrobial. Meningococcal meningitis requires CNS-penetrating IV ceftriaxone. Lyme disease in pregnancy requires amoxicillin to avoid tetracycline teratogenicity. Primary syphilis is definitively treated with IM penicillin G benzathine. Uncomplicated cystitis is safely managed with oral nitrofurantoin.

Step-by-Step Solution

1
Identify the likely pathogen and disease state for the first presentation.
Gram-negative diplococci in CSF indicates Neisseria meningitidis meningitis.
Recognizing the pathogen is necessary to select the appropriate targeted therapy.
2
Determine the appropriate treatment for meningococcal meningitis.
Intravenous ceftriaxone.
Third-generation cephalosporins are the standard of care for empiric and targeted therapy of N. meningitidis meningitis.
3
Identify the disease and patient constraints for the second presentation.
Erythema migrans indicates Lyme disease in a pregnant patient.
Pregnancy alters the standard treatment algorithm for early Lyme disease.
4
Select the appropriate alternative treatment for Lyme disease in pregnancy.
Oral amoxicillin.
Doxycycline is teratogenic, making amoxicillin the preferred safe alternative.
5
Identify the disease and stage for the third presentation.
Painless chancre indicates primary syphilis.
Accurate staging dictates the required dosage and duration of penicillin therapy.
6
Select the standard treatment for primary syphilis.
Intramuscular penicillin G benzathine.
A single dose of long-acting penicillin is curative for primary syphilis.
7
Identify the diagnosis for the fourth presentation.
Symptoms and positive nitrites without systemic signs indicate uncomplicated cystitis.
Differentiating uncomplicated cystitis from pyelonephritis dictates oral versus systemic/broad therapy.
8
Select the appropriate first-line therapy for uncomplicated cystitis.
Oral nitrofurantoin.
Nitrofurantoin concentrates well in the urine and is a preferred first-line agent.

Key Concept

Selection of first-line targeted antimicrobial therapy for common infectious diseases while accounting for patient-specific contraindications.
Question 2348Question →

A 45-year-old man presents to the outpatient clinic with a 2-day history of right calf pain and swelling. He recently returned from a 14-hour international flight. He has no chest pain, shortness of breath, or hemoptysis. His medical history is unremarkable, and he takes no medications.

Vital signs are:
Temperature: 37.0°C (98.6°F)
Heart rate: 78/min
Blood pressure: 125/80 mmHg
Respiratory rate: 14/min
Oxygen saturation: 98% on room air

Physical examination reveals a 4 cm increase in the circumference of the right calf compared to the left. The right calf is warm, tender to palpation, and exhibits mild erythema.

Laboratory panels reveal:
Hemoglobin: 14.8 g/dL
Mean corpuscular volume (MCV): 88 fL
Platelet count: 260,000/mm³
White blood cell count: 8,100/mm³
Serum creatinine: 0.9 mg/dL
Prothrombin time (PT): 12 seconds
Activated partial thromboplastin time (aPTT): 30 seconds

A comprehensive duplex ultrasonography of the right lower extremity demonstrates a non-compressible segment in the right popliteal vein.

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Initiate oral apixaban therapy

Answer

The most appropriate next step in management is to initiate oral apixaban therapy.
This patient has a confirmed, uncomplicated acute deep venous thrombosis (DVT) in the popliteal vein. He is hemodynamically stable, has normal renal function (creatinine 0.9 mg/dL), and has no active bleeding or high-risk comorbidities. The standard of care for an initial episode of proximal DVT is immediate therapeutic anticoagulation. Direct oral anticoagulants (DOACs) such as apixaban or rivaroxaban are currently preferred over warfarin because they have a rapid onset of action, do not require a parenteral bridging agent (like low-molecular-weight heparin), and do not require routine laboratory monitoring. Since the patient is completely stable with normal vital signs, he can be safely treated in the outpatient setting.

Step-by-Step Solution

1
Evaluate the clinical presentation and diagnostic findings.
The patient has signs, symptoms, and a confirmed ultrasound diagnosis of an acute right popliteal deep venous thrombosis (DVT).
To establish the correct diagnosis before initiating any targeted treatment.
2
Assess the patient's clinical stability and bleeding risk profile.
The patient is hemodynamically stable, has normal renal function, and normal baseline coagulation panels.
To determine the appropriate setting (inpatient vs. outpatient) and ensure there are no contraindications to anticoagulation.
3
Select the optimal therapeutic intervention.
Initiation of a direct oral anticoagulant (DOAC) such as apixaban.
DOACs are the standard of care for acute, uncomplicated DVT because they are highly effective, do not require laboratory monitoring, and can be administered orally in an outpatient setting.

Key Concept

Management of acute, uncomplicated deep venous thrombosis (DVT) with direct oral anticoagulants.
Question 2349Question →

A 6565-year-old man visits the clinic reporting a 33-week history of profound fatigue, subjective fevers, and widespread joint pain. He notes that his wrists, knees, and ankles feel stiff and swollen. His past medical history is significant for ischemic cardiomyopathy with a reduced ejection fraction and chronic obstructive pulmonary disease. His daily medications include carvedilol, lisinopril, furosemide, hydralazine, and a tiotropium inhaler. Vital signs show a temperature of 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), blood pressure of 128/78 mmHg128/78\text{ mmHg}, and heart rate of 76/min76/\text{min}. Physical examination reveals mild symmetric effusions in the knees and wrists without overlying erythema. Cardiopulmonary examination reveals normal heart sounds without murmurs, and clear lung fields bilaterally.

Laboratory investigations reveal the following:

Laboratory TestResultReference Range
Antinuclear antibodies (ANA)Positive (1:6401:640)Negative
Anti-double-stranded DNANegativeNegative
Anti-histone antibodiesPositiveNegative
Rheumatoid factor (RF)NegativeNegative
Thyroid-stimulating hormone (TSH)2.1 \muU/mL2.1\text{ \mu U/mL}0.4−4.0 \muU/mL0.4-4.0\text{ \mu U/mL}

Based on the patient's clinical presentation and laboratory findings, which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinuation of hydralazine

Answer

Discontinuation of hydralazine
The correct answer involves discontinuing hydralazine because the patient's clinical picture is highly characteristic of drug-induced lupus erythematosus (DILE). DILE presents with systemic symptoms such as fever, fatigue, and polyarthritis. The serological hallmark is a positive ANA and the presence of anti-histone antibodies, with a notable absence of anti-dsDNA antibodies (which are more specific to idiopathic systemic lupus erythematosus). Hydralazine is one of the most common medications known to cause DILE. The cornerstone of management is simply stopping the offending medication, which typically results in complete resolution of symptoms over several weeks.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings.
The patient has new-onset polyarthralgia, fatigue, and fever. Labs show positive ANA and positive anti-histone antibodies, but negative anti-dsDNA and negative RF.
Synthesizing symptoms with targeted serology is required to narrow the rheumatologic differential diagnosis.
2
Correlate the serologic profile with the patient's medication list.
The combination of positive ANA and anti-histone antibodies is the classic serologic signature for drug-induced lupus erythematosus (DILE). Hydralazine is a well-known high-risk medication for DILE.
Identifying the causative agent is the critical step in diagnosing a drug-induced autoimmune phenomenon.
3
Determine the appropriate therapeutic intervention.
The primary and most effective treatment for DILE is the removal of the offending drug.
Discontinuing hydralazine leads to the resolution of clinical symptoms, making it the most appropriate next step in management.

Key Concept

Drug-induced lupus erythematosus (DILE) classically presents with constitutional symptoms, arthralgias, positive ANA, and positive anti-histone antibodies, often triggered by medications like hydralazine or procainamide. The primary treatment is discontinuing the offending drug.
Estimated Time:1m 15s
Question 2350Question →

Match each neonatal clinical vignette with its primary underlying pathophysiology.

Click a left item, then click its matching right item

Items

A 39-week gestation infant delivered via elective cesarean section without antecedent labor develops tachypnea and retractions. Chest radiography demonstrates fluid in the minor fissure and prominent perihilar streaking.
A 29-week gestation neonate presents with grunting and cyanosis in the delivery room. Chest radiography reveals low lung volumes, a diffuse bilateral reticulogranular pattern, and prominent air bronchograms.
A 41-week gestation infant is born limp and cyanotic. The chest is barrel-shaped. Radiography reveals patchy, asymmetric bilateral infiltrates with hyperinflation and flattened hemidiaphragms.
A 38-week gestation infant develops severe hypoxemia and central cyanosis. The chest radiograph is relatively clear with normal lung volumes. Echocardiography shows right-to-left shunting across a patent foramen ovale and ductus arteriosus with structurally normal heart anatomy.

Matches

Show answer & explanation

Answer

Match Transient Tachypnea of the Newborn (TTN) to delayed fluid clearance, Respiratory Distress Syndrome (RDS) to surfactant deficiency, Meconium Aspiration Syndrome (MAS) to airway obstruction and pneumonitis, and Persistent Pulmonary Hypertension of the Newborn (PPHN) to failure of pulmonary vascular resistance decline.
Each clinical scenario correctly describes a classic presentation of a major neonatal respiratory disorder, and the corresponding correct match accurately defines the specific pathophysiologic mechanism for that disorder. The two-step reasoning requires identifying the disease (TTN, RDS, MAS, PPHN) and subsequently linking it to its physiologic disruption.

Step-by-Step Solution

1
Analyze the first vignette to determine the diagnosis.
The combination of term birth, elective cesarean section without labor, fluid in fissures, and perihilar streaking strongly indicates Transient Tachypnea of the Newborn (TTN).
Identifying the specific clinical syndrome is necessary to match it with its underlying pathophysiology.
2
Match TTN to its pathophysiology.
TTN is matched to 'Delayed resorption and clearance of fetal alveolar fluid...'
During vaginal labor, hormonal surges (like catecholamines) trigger the reabsorption of fetal lung fluid. Elective cesareans bypass this process, causing transient retained fluid.
3
Analyze the second vignette to determine the diagnosis.
The presentation of a premature infant with ground-glass opacities and air bronchograms is the classic description of Respiratory Distress Syndrome (RDS).
Recognizing the radiographic and clinical hallmark of RDS in prematurity.
4
Match RDS to its pathophysiology.
RDS is matched to 'Quantitative deficiency of type II pneumocyte secretions...'
Premature lungs lack sufficient surfactant production, leading to high alveolar surface tension, atelectasis, and hypoxemia.
5
Analyze the third vignette to determine the diagnosis.
A post-term infant with barrel-chest, hyperinflation, and asymmetric patchy opacities is characteristic of Meconium Aspiration Syndrome (MAS).
Identifying MAS based on post-term status and radiographic evidence of airway obstruction and inflammation.
6
Match MAS to its pathophysiology.
MAS is matched to 'Mechanical airway obstruction causing a ball-valve effect...'
Meconium physically blocks the airways (air trapping/hyperinflation) and causes a chemical pneumonitis that inactivates surfactant.
7
Analyze the fourth vignette to determine the diagnosis.
Severe hypoxemia out of proportion to lung disease, with right-to-left shunting on a structurally normal heart, points to Persistent Pulmonary Hypertension of the Newborn (PPHN).
Ruling out cyanotic congenital heart disease and identifying the functional shunting.
8
Match PPHN to its pathophysiology.
PPHN is matched to 'Failure of normal postnatal decline in pulmonary vascular resistance...'
High pulmonary pressures force blood to bypass the lungs via the patent foramen ovale and ductus arteriosus, causing systemic hypoxemia.

Key Concept

Neonatal respiratory distress conditions can be differentiated by gestational age, risk factors, and radiographic findings, which correlate directly with distinct pathophysiologic mechanisms.
Question 2351Question →

A 52-year-old man presents to the urgent care clinic due to severe pain, redness, and swelling in his left big toe. The symptoms started abruptly early this morning and have progressively worsened, making it difficult for him to walk. He has a medical history of hypertension, for which he takes hydrochlorothiazide. His temperature is 37.2°C (99.0°F), blood pressure is 135/85 mm Hg, and pulse is 88/min. Physical examination reveals a remarkably tender, erythematous, and warm left first metatarsophalangeal joint with significant swelling. An arthrocentesis is performed, and synovial fluid analysis demonstrates a leukocyte count of 25,000/mm³ with negatively birefringent, needle-shaped crystals under polarized light microscopy. Gram stain of the fluid shows no organisms, and his serum creatinine is 0.9 mg/dL. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Administration of oral naproxen

Answer

Administration of oral naproxen
The correct answer is administration of oral naproxen. This patient presents with a classic acute flare of gout, characterized by severe, rapid-onset monoarthritis of the first metatarsophalangeal joint (podagra). The diagnosis is definitively established by synovial fluid analysis demonstrating needle-shaped, negatively birefringent monosodium urate crystals. The use of hydrochlorothiazide is a known risk factor, as thiazide diuretics decrease the renal excretion of uric acid. For the management of an acute gout flare, first-line therapies include nonsteroidal anti-inflammatory drugs (NSAIDs) like naproxen or indomethacin, colchicine, or glucocorticoids. Given the patient's normal serum creatinine and lack of stated contraindications, an NSAID is a highly effective and appropriate initial therapy to reduce acute inflammation.

Step-by-Step Solution

1
Analyze the clinical presentation and physical exam findings.
The patient has acute, highly inflammatory monoarticular arthritis of the first metatarsophalangeal joint (podagra), strongly suggesting a crystal-induced arthropathy or infectious etiology.
Identifying the clinical syndrome is the first step in formulating a differential diagnosis.
2
Interpret the synovial fluid analysis.
The fluid shows a moderately elevated leukocyte count (25,000/mm³) and negatively birefringent needle-shaped crystals, with a negative Gram stain.
These findings definitively confirm the diagnosis of acute gout caused by monosodium urate crystals and rule out septic arthritis.
3
Determine the most appropriate initial therapy for the confirmed diagnosis.
Oral NSAIDs (such as naproxen, indomethacin, or ibuprofen), colchicine, or systemic/intra-articular corticosteroids are the mainstays of acute gout treatment.
Since the patient has normal renal function (creatinine 0.9 mg/dL) and no stated contraindications, an oral NSAID is the most appropriate next step to quickly resolve the severe inflammation.

Key Concept

The diagnosis of acute gout is confirmed by the presence of negatively birefringent, needle-shaped monosodium urate crystals in synovial fluid. First-line therapy for an acute flare includes NSAIDs, colchicine, or corticosteroids.
Estimated Time:1m 0s
Question 2352Question →

A 72-year-old man with a history of a bioprosthetic aortic valve replacement three years ago is hospitalized due to a 4-week history of low-grade fever, progressive fatigue, and night sweats. On physical examination, his temperature is 38.2∘C38.2^\circ\text{C} (100.8∘F100.8^\circ\text{F}), blood pressure is 118/76 mmHg118/76\text{ mmHg}, and heart rate is 92/min92/\text{min}. A new grade 2/6 diastolic decrescendo murmur is heard at the right upper sternal border. Laboratory evaluation shows a leukocyte count of 14,500/mm314,500/\text{mm}^3 and a serum creatinine of 1.1 mg/dL1.1\text{ mg/dL}. Transesophageal echocardiography reveals a 1.4 cm1.4\text{ cm} vegetation on the prosthetic valve. Three sets of blood cultures obtained prior to antibiotic administration are all positive for *Enterococcus faecalis*. The patient is empirically started on intravenous vancomycin and gentamicin.

Antimicrobial susceptibility testing for the isolate demonstrates the following:
* Ampicillin: Susceptible
* Penicillin: Susceptible
* Vancomycin: Susceptible
* Gentamicin: High-level resistance

Which of the following is the most appropriate antimicrobial regimen for this patient?

Show answer & explanation

Answer: Intravenous ampicillin and intravenous ceftriaxone

Answer

The most appropriate regimen is intravenous ampicillin and intravenous ceftriaxone.
The correct answer is the combination of intravenous ampicillin and intravenous ceftriaxone. Enterococcal endocarditis requires bactericidal therapy, which is conventionally achieved through the synergistic combination of a cell-wall active agent (like ampicillin) and an aminoglycoside (like gentamicin). However, this isolate demonstrates high-level gentamicin resistance (HLAR). HLAR indicates that the synergistic bactericidal effect is lost, rendering the addition of an aminoglycoside not only ineffective but also unnecessarily nephrotoxic. The combination of ampicillin and ceftriaxone is a well-established, highly effective alternative. Ceftriaxone alone has minimal activity against Enterococcus, but it saturates specific complementary penicillin-binding proteins (PBPs), specifically PBP2 and PBP3, which allows ampicillin to exert a potent synergistic bactericidal effect. This combination is effective regardless of HLAR and avoids aminoglycoside-induced nephrotoxicity, making it the standard of care.

Step-by-Step Solution

1
Identify the primary diagnosis and pathogen.
The patient has prosthetic valve infective endocarditis caused by Enterococcus faecalis.
Vegetation on a prosthetic valve with positive blood cultures establishes the diagnosis of infective endocarditis, requiring prolonged bactericidal therapy.
2
Evaluate the antimicrobial susceptibility results.
The isolate is susceptible to ampicillin but exhibits high-level resistance to gentamicin.
Targeted therapy must be selected based on susceptibility to maximize efficacy and minimize toxicity (antibiotic stewardship).
3
Determine the optimal bactericidal regimen.
Select ampicillin combined with ceftriaxone.
Enterococcal endocarditis requires synergistic bactericidal therapy. Because high-level gentamicin resistance abolishes synergy with aminoglycosides, the ampicillin plus ceftriaxone combination is required. Ceftriaxone saturates complementary penicillin-binding proteins (PBPs), restoring bactericidal synergy with ampicillin.

Key Concept

Treatment of Enterococcus faecalis endocarditis
Question 2353Question →

Match each clinical scenario describing a patient undergoing pharmacotherapy for a rheumatologic condition to the critical screening, prophylaxis, or adverse effect monitoring mandated by their specific medication.

Click a left item, then click its matching right item

Items

A 55-year-old woman with severe, tophaceous gout refractory to standard urate-lowering therapies is scheduled to begin intravenous infusions of pegloticase.
A 62-year-old man with rheumatoid arthritis has an inadequate response to methotrexate and is initiated on tofacitinib, an oral Janus kinase (JAK) inhibitor.
A 28-year-old woman with severe systemic lupus erythematosus and biopsy-proven class IV lupus nephritis is being induced with intravenous cyclophosphamide.
A 35-year-old man with ankylosing spondylitis is preparing to start infliximab, a chimeric monoclonal antibody directed against tumor necrosis factor-alpha.
A 45-year-old woman with seropositive rheumatoid arthritis is preparing to receive rituximab, a B-lymphocyte depleting agent, after failing multiple other therapies.

Matches

Show answer & explanation

Answer

Pegloticase requires G6PD screening; Tofacitinib requires monitoring for cardiovascular events/thrombosis and herpes zoster; Cyclophosphamide requires Mesna prophylaxis for acrolein toxicity; Infliximab requires latent TB screening; Rituximab requires Hepatitis B screening.
Each immunosuppressive or immunomodulatory medication has a unique toxicity profile dictated by its mechanism of action. TNF inhibitors disrupt granulomas (TB risk). Rituximab depletes B-cells (HBV risk). Cyclophosphamide produces acrolein (bladder toxicity needing mesna). Pegloticase causes oxidative stress (hemolysis in G6PD deficiency). JAK inhibitors carry distinct risks for thrombosis and herpes zoster reactivation.

Step-by-Step Solution

1
Analyze the mechanism of action of pegloticase in gout management.
Pegloticase generates oxidative stress via hydrogen peroxide production, linking it to the need for G6PD deficiency screening.
G6PD deficient red blood cells cannot process oxidative stress, leading to hemolysis and methemoglobinemia.
2
Evaluate the specific boxed warnings associated with JAK inhibitors like tofacitinib.
JAK inhibitors are uniquely associated with increased risks of herpes zoster, venous thromboembolism (VTE), and major adverse cardiovascular events (MACE).
These specific adverse effects dictate pre-treatment cardiovascular risk stratification and zoster vaccination.
3
Recall the metabolism and target-organ toxicity of cyclophosphamide.
It metabolizes to acrolein, which concentrates in the bladder. Mesna acts as the specific antidote.
Mesna provides sulfhydryl groups that bind acrolein in the urinary tract, preventing hemorrhagic cystitis.
4
Identify the critical role of TNF-alpha in host immune defense.
TNF-alpha maintains granulomas; its inhibition by infliximab destabilizes them, risking tuberculosis reactivation.
Screening via IGRA or PPD is mandatory before initiating any TNF-alpha inhibitor.
5
Determine the unique infectious risks of severe B-cell depletion with rituximab.
Loss of antibody-mediated immunity drastically increases the risk of Hepatitis B reactivation.
Universal screening for HBsAg and anti-HBc is mandated prior to rituximab therapy to prevent fulminant hepatitis.

Key Concept

Essential pre-treatment screening, prophylaxis, and monitoring for targeted disease-modifying therapies in rheumatology.
Estimated Time:2m 30s
Question 2354Question →

Match each clinical presentation of a severe electrolyte abnormality to the most appropriate initial therapeutic intervention.

Click a left item, then click its matching right item

Items

A 62-year-old woman with small cell lung cancer who presents with a generalized tonic-clonic seizure. Laboratory studies show a serum sodium of 114114 mEq/L and urine osmolality of 510510 mOsm/kg.
A 71-year-old man with stage 4 chronic kidney disease who presents with profound generalized weakness. Electrocardiogram reveals peaked T waves and widened QRS complexes. Serum potassium is 7.67.6 mEq/L.
A 48-year-old man with chronic alcohol use disorder who presents with severe muscle cramps. Serum potassium is 2.62.6 mEq/L. Despite continuous intravenous potassium replacement over several hours, his potassium level remains persistently low.
A 56-year-old woman with sarcoidosis who presents with severe lethargy, diffuse abdominal pain, and polyuria. Serum calcium is 14.114.1 mg/dL. Her mucous membranes are exceedingly dry.

Matches

Show answer & explanation

Answer

Symptomatic hyponatremia is treated with hypertonic saline; hyperkalemia with ECG changes requires calcium gluconate; refractory hypokalemia needs magnesium sulfate; and severe hypercalcemia requires aggressive hydration with normal saline.
Each clinical scenario represents a distinct electrolyte emergency dictating a specific initial therapeutic priority. Symptomatic hyponatremia with neurological impairment mandates hypertonic saline to reduce cerebral edema. Hyperkalemia manifesting with widened QRS complexes requires immediate membrane stabilization with calcium gluconate. Hypokalemia that is refractory to standard potassium replacement suggests concomitant hypomagnesemia, requiring magnesium repletion to halt renal potassium wasting. Severe hypercalcemia causes profound diuresis and volume contraction, necessitating aggressive fluid resuscitation with normal saline to restore perfusion and promote urinary calcium excretion.

Step-by-Step Solution

1
Evaluate the patient presenting with severe hyponatremia and seizures.
Identify this as an acute neurological emergency caused by cerebral edema.
Neurologic symptoms in the setting of hyponatremia (SIADH) demand rapid but controlled correction of serum sodium using hypertonic saline to prevent irreversible brain injury.
2
Evaluate the patient with severe hyperkalemia and widened QRS complexes.
Recognize the imminent risk of fatal ventricular arrhythmias.
Immediate stabilization of the cardiac myocyte membrane with calcium gluconate is prioritized over interventions that shift or excrete potassium.
3
Evaluate the patient with hypokalemia that does not respond to intravenous replacement.
Identify concurrent hypomagnesemia as the barrier to potassium correction.
Magnesium deficiency prevents the closure of renal outer medullary potassium (ROMK) channels, leading to continuous potassium loss in the urine until magnesium is replenished.
4
Evaluate the patient with severe hypercalcemia and signs of severe dehydration.
Recognize that hypercalcemia-induced diuresis has caused massive volume depletion.
Aggressive isotonic fluid resuscitation is the first required step before administering definitive calcium-lowering therapies (like bisphosphonates or calcitonin) to dilute the calcium and restore glomerular filtration.

Key Concept

Initial emergency management of severe electrolyte disturbances
Question 2355Question →

A 7272-year-old woman is evaluated on hospital day 33 for ongoing medication management. She was initially admitted for a severe diabetic foot infection complicated by septic shock. On admission, her blood pressure was 85/50 mmHg85/50 \text{ mmHg}, which responded to aggressive intravenous fluid resuscitation. She was empirically started on broad-spectrum intravenous vancomycin and piperacillin-tazobactam. Due to initial profound lethargy and confusion in the emergency department, a comprehensive laboratory workup, including thyroid function tests, was obtained.

Today, the patient is alert, afebrile, and hemodynamically stable. Blood cultures and deep wound cultures from admission both exclusively grow methicillin-susceptible *Staphylococcus aureus* (MSSA). Laboratory results from the admission draw are now available and shown below:

Laboratory TestResultReference Range
TSH0.15 mIU/L0.15 \text{ mIU/L}0.4−4.0 mIU/L0.4-4.0 \text{ mIU/L}
Free T40.6 ng/dL0.6 \text{ ng/dL}0.9−1.7 ng/dL0.9-1.7 \text{ ng/dL}
Total T355 ng/dL55 \text{ ng/dL}80−200 ng/dL80-200 \text{ ng/dL}

Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Discontinue vancomycin and piperacillin-tazobactam, begin intravenous cefazolin, and provide no thyroid-specific intervention

Answer

Discontinue vancomycin and piperacillin-tazobactam, begin intravenous cefazolin, and provide no thyroid-specific intervention.
The most appropriate management for this patient involves two critical clinical decisions: proper antibiotic de-escalation and the correct interpretation of thyroid function abnormalities in critical illness. First, the patient's cultures grew methicillin-susceptible Staphylococcus aureus (MSSA). Continuing empiric broad-spectrum coverage (vancomycin and piperacillin-tazobactam) is contrary to antibiotic stewardship principles. Targeted, narrow-spectrum beta-lactams such as intravenous cefazolin or nafcillin are the superior agents for MSSA infections, providing better clearance and fewer adverse effects. Second, the patient's admission thyroid panel reveals low total T3, low free T4, and low TSH. This pattern, seen in the context of a severe stressor like septic shock, is classic for euthyroid sick syndrome (also known as non-thyroidal illness syndrome). It is characterized primarily by decreased peripheral conversion of T4 to T3, followed by central suppression of TSH and subsequent decreases in T4 as the illness severity worsens. Because this is a physiologic adaptation to stress and not a true thyroid pathology, no intervention (e.g., levothyroxine) or further diagnostic imaging (e.g., MRI) is indicated. Thyroid function typically normalizes weeks after recovery from the primary illness.

Step-by-Step Solution

1
Evaluate culture results and optimize antimicrobial therapy.
Cultures exclusively grew MSSA, indicating that broad-spectrum coverage with vancomycin and piperacillin-tazobactam is no longer appropriate.
Antimicrobial stewardship dictates transitioning to a narrow-spectrum, highly effective agent such as cefazolin or nafcillin for MSSA bacteremia.
2
Interpret the abnormal thyroid function tests in the context of the patient's severe acute illness.
The patient has low T3, low free T4, and low TSH obtained during an episode of septic shock.
This pattern is the hallmark of euthyroid sick syndrome (non-thyroidal illness syndrome), a physiologic adaptation to critical illness rather than true glandular pathology.
3
Determine the therapeutic requirement for the thyroid abnormalities.
No thyroid-specific intervention, imaging, or hormone replacement should be pursued.
Euthyroid sick syndrome resolves spontaneously as the underlying illness improves; exogenous thyroid hormone administration is not beneficial and can be harmful.

Key Concept

Management of euthyroid sick syndrome during critical illness and antibiotic stewardship for MSSA bacteremia
Question 2356Question →

An evaluation is requested for a 67-year-old male patient who reports a persistent sore on the bottom of his right foot for the past two months. He has a 15-year history of type 2 diabetes mellitus complicated by peripheral neuropathy. His vital signs include a blood pressure of 135/85 mm Hg, a heart rate of 76/min, and a temperature of 37.0°C (98.6°F). On physical examination, there is a 2.5-cm, painless ulcer on the plantar aspect of the right first metatarsal head. There is no significant surrounding erythema, warmth, or fluctuance. During exploration of the wound, a sterile metallic probe easily contacts hard, gritty tissue at the base of the ulcer. Laboratory testing reveals a leukocyte count of 8,200/mm³ and an erythrocyte sedimentation rate of 95 mm/h. Radiography of the right foot demonstrates focal periosteal elevation and frank cortical erosion of the underlying metatarsal head. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Perform a sterile bone biopsy for microbiologic culture

Answer

Perform a sterile bone biopsy for microbiologic culture
The correct action is to perform a sterile bone biopsy. This patient has a confirmed case of diabetic foot osteomyelitis based on a positive probe-to-bone test and diagnostic plain radiographs showing cortical destruction. Because the patient is hemodynamically stable and has no systemic signs of severe infection (such as fever or extensive cellulitis), there is no indication for emergent empiric antibiotics. The standard of care is to withhold antimicrobial therapy until a bone biopsy can be obtained. This ensures accurate identification of the offending organism and its susceptibility profile, which is critical since diabetic foot infections are frequently polymicrobial or involve resistant organisms. Targeted therapy minimizes toxicity and adheres to principles of antimicrobial stewardship.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and diagnostic findings.
The patient has a chronic diabetic foot ulcer with a positive probe-to-bone test, elevated ESR, and plain radiograph findings of cortical erosion, which are collectively diagnostic of osteomyelitis.
Establishing a definitive diagnosis is required before determining the appropriate management pathway.
2
Assess the patient's hemodynamic stability and the urgency of treatment.
The patient is afebrile, normocardic, and lacks severe surrounding cellulitis or signs of sepsis.
Stable patients do not require emergent empiric antibiotics, allowing time for optimal diagnostic sampling.
3
Select the optimal diagnostic step to guide antimicrobial therapy.
A sterile bone biopsy is chosen over superficial swabs or empiric treatment.
Bone biopsy provides a definitive microbiologic diagnosis, allowing for targeted antimicrobial therapy in accordance with antibiotic stewardship principles.

Key Concept

In clinically stable patients with diabetic foot osteomyelitis, obtaining a deep tissue or bone biopsy for microbiologic culture prior to initiating antimicrobial therapy is essential to ensure targeted, effective treatment and prevent the selection of resistant organisms.
Question 2357Question →

A hematology consultation service is reviewing the coagulation profiles of four adult patients, all of whom present with unexplained prolonged coagulation times on routine preoperative screening. Based on the specific specialized laboratory testing kinetics provided, match each patient's coagulation profile to the most accurate underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

Patient 1: Prolonged aPTT. A 1:1 mixing study with normal plasma immediately corrects the aPTT to normal. However, after a 2-hour incubation at 37°C, the aPTT becomes significantly prolonged again.
Patient 2: Prolonged aPTT. A 1:1 mixing study with normal plasma fails to correct the aPTT immediately. The subsequent addition of excess hexagonal phase phospholipid normalizes the aPTT.
Patient 3: Prolonged PT and aPTT. A 1:1 mixing study immediately corrects both parameters. Specific assays reveal severely reduced activities of Factors II, VII, IX, and X.
Patient 4: Prolonged aPTT with normal PT. A 1:1 mixing study immediately corrects the aPTT, which remains corrected after a 2-hour incubation. Factor XI activity is measured at <1%.

Matches

Show answer & explanation

Answer

Patient 1 matches acquired factor VIII inhibitor (time-dependent inhibition). Patient 2 matches lupus anticoagulant (phospholipid interference). Patient 3 matches Vitamin K deficiency (impaired gamma-carboxylation). Patient 4 matches Factor XI deficiency (autosomal recessive contact pathway).
The correct pairings accurately reflect the physiological and biochemical behavior of different hemostatic disorders in the laboratory setting. Mixing studies uniquely distinguish between physical absences of factors (which correct) and the presence of interfering antibodies (which do not correct, either immediately or after incubation).

Step-by-Step Solution

1
Analyze Patient 1's mixing study kinetics.
Initial correction with delayed prolongation indicates a time-dependent inhibitor.
Acquired Hemophilia A (Factor VIII inhibitor) autoantibodies are classically time- and temperature-dependent, initially appearing as a deficiency but revealing their inhibitory nature after incubation.
2
Analyze Patient 2's mixing study kinetics.
Immediate failure to correct indicates an inhibitor; correction with hexagonal phase phospholipid confirms lupus anticoagulant.
Lupus anticoagulants are autoantibodies that directly bind and neutralize the phospholipids used in the aPTT assay reagent, causing an immediate, non-time-dependent prolongation.
3
Evaluate Patient 3's coagulation profile.
Prolongation of both PT and aPTT that completely corrects on mixing indicates a multiple factor deficiency involving Factors II, VII, IX, and X.
These specific factors rely on Vitamin K as a cofactor for the gamma-glutamyl carboxylase enzyme, which allows them to bind calcium and phospholipid surfaces.
4
Evaluate Patient 4's coagulation profile.
Isolated aPTT prolongation that corrects and stays corrected indicates an intrinsic factor deficiency (Factor XI).
A pure deficiency lacks any inhibitory antibodies, so adding normal plasma fully and permanently replenishes the missing factor, resulting in a sustained normal aPTT.

Key Concept

Interpretation of time-dependent versus immediate mixing study kinetics to differentiate coagulation factor deficiencies from acquired inhibitors.
Estimated Time:2m 0s
Question 2358Question →

An infant girl born at 38 weeks gestation is assessed in the nursery at 30 hours of life due to new-onset temperature instability and increased work of breathing. Her mother received limited prenatal care. The infant was previously vigorous but has become progressively lethargic over the past 4 hours. Current vital signs include a temperature of 38.7°C (101.7°F), heart rate of 185/min, and respiratory rate of 76/min. On physical examination, she demonstrates nasal flaring, marked intercostal retractions, and hypotonia. Dermatologic examination reveals a diffuse eruption of 1- to 3-mm pustules surrounded by erythematous macules on her chest and abdomen; the palms and soles are clear. Following the collection of blood, urine, and cerebrospinal fluid for culture, which of the following is the most appropriate empiric pharmacologic intervention for this patient?

Show answer & explanation

Answer: Intravenous ampicillin and cefotaxime

Answer

Intravenous ampicillin and cefotaxime
The correct intervention is intravenous ampicillin and cefotaxime. This patient presents with classic signs of early-onset neonatal sepsis, including temperature instability, severe respiratory distress, and progressive lethargy. The most common pathogens responsible for early-onset sepsis are Group B Streptococcus (GBS), Escherichia coli, and Listeria monocytogenes. Empiric therapy must cover these organisms. Ampicillin provides excellent coverage for GBS and Listeria. Cefotaxime, a third-generation cephalosporin, provides excellent coverage against Gram-negative organisms like E. coli and has strong central nervous system penetration. The patient's dermatologic presentation is erythema toxicum neonatorum, a benign condition that requires no treatment and should not distract from the urgent need for systemic antibacterials.

Step-by-Step Solution

1
Identify the primary clinical syndrome
The infant demonstrates fever, tachypnea, retractions, and lethargy at 30 hours of life, which is highly indicative of early-onset neonatal sepsis.
Systemic signs of infection in a newborn within the first 72 hours of life require immediate evaluation and broad empiric antibacterial coverage.
2
Analyze the dermatologic findings
The rash consists of small pustules on an erythematous base sparing the palms and soles in a term infant, which is classic for erythema toxicum neonatorum.
Recognizing this specific rash as benign prevents unnecessary diversion toward viral or localized dermatologic diagnoses.
3
Select the appropriate empiric pharmacotherapy
Intravenous ampicillin and cefotaxime is chosen to safely cover the most common neonatal pathogens without causing hyperbilirubinemia complications.
Ampicillin covers Group B Streptococcus and Listeria, while cefotaxime provides Gram-negative (e.g., E. coli) coverage without the kernicterus risk seen with ceftriaxone.

Key Concept

Empiric treatment of early-onset neonatal sepsis requires intravenous ampicillin combined with either an aminoglycoside (e.g., gentamicin) or a safe third-generation cephalosporin (e.g., cefotaxime), while recognizing and ignoring concurrent benign findings like erythema toxicum neonatorum.
Estimated Time:1m 15s
Question 2359Question →

A 3535-year-old man presents to the clinic with an 88-day history of a persistent cough. He states that the cough is productive of yellowish sputum and is occasionally accompanied by mild retrosternal chest soreness. He reports having a runny nose and a low-grade fever that resolved 33 days ago. He has no significant past medical history and does not smoke. Vital signs are temperature 37.2∘C37.2^\circ \text{C} (99.0∘F99.0^\circ \text{F}), blood pressure 122/78 mmHg122/78 \, \text{mmHg}, pulse 78/min78/\text{min}, and respiratory rate 16/min16/\text{min}. Pulse oximetry is 98%98\% on room air. Physical examination reveals normal tympanic membranes, mild pharyngeal erythema without exudate, and clear lung fields bilaterally without wheezes, rhonchi, or crackles. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Observation and symptomatic management

Answer

Observation and symptomatic management
The patient's presentation is classic for acute bronchitis, a lower respiratory tract infection primarily affecting the large airways. Over 90%90\% of cases are caused by respiratory viruses (e.g., rhinovirus, influenza, coronavirus, RSV). The hallmarks are a cough lasting 11 to 33 weeks, often following a typical viral upper respiratory infection. Crucially, the presence of yellow or green sputum does NOT signify a bacterial infection; it simply reflects the presence of sloughed airway epithelial cells and neutrophils. Because the patient has normal vital signs and a normal pulmonary examination (no crackles, egophony, or tactile fremitus), community-acquired pneumonia is effectively ruled out. Therefore, chest radiography is unnecessary, and the most appropriate management is strict observation and symptomatic relief (e.g., NSAIDs, dextromethorphan, or guaifenesin). The administration of antibiotics for acute bronchitis is a major driver of antibiotic resistance and violates core principles of antimicrobial stewardship.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has a cough lasting 8 days, purulent sputum, and prior URI symptoms, but normal vital signs and clear lung fields.
Differentiating uncomplicated acute bronchitis from community-acquired pneumonia requires assessing for systemic toxicity, abnormal vitals, and focal consolidation.
2
Determine the likely diagnosis.
The diagnosis is acute bronchitis, which is almost exclusively viral.
The absence of fever, tachycardia, tachypnea, and focal crackles makes bacterial pneumonia highly unlikely.
3
Select the appropriate management strategy based on antimicrobial stewardship principles.
Observation and symptomatic management are chosen.
Antibiotics do not improve outcomes in acute viral bronchitis. Purulent sputum alone is not an indication for antibiotics.

Key Concept

Antibiotic stewardship in acute bronchitis
Estimated Time:45s
Question 2360Question →

A couple brings their 8-month-old son to the pediatric clinic for a pre-travel consultation. They are scheduled to relocate temporarily to a rural region in Sub-Saharan Africa in two weeks. This region currently has high endemic rates of both measles and hepatitis A. The boy was born prematurely at 32 weeks gestation following an uncomplicated pregnancy and neonatal course. His routine immunizations are up to date according to his chronological age. The parents report that he has had mild nasal congestion and a clear nasal discharge for the past two days. On examination, his temperature is 37.6°C (99.7°F). He is playful, well-appearing, and in no respiratory distress. Neurologic examination reveals that he is able to roll from back to front and sits leaning forward on his hands, but he falls over when his hands are removed. Which of the following is the most appropriate management plan for this patient today?

Show answer & explanation

Answer: Administer measles-mumps-rubella (MMR) and hepatitis A vaccines, and advise that both will need to be re-administered starting at age 12 months

Answer

Administer measles-mumps-rubella (MMR) and hepatitis A vaccines, and advise that both will need to be re-administered starting at age 12 months
The most appropriate management is to administer both the MMR and hepatitis A vaccines today, and advise the parents that these doses will need to be repeated starting at 12 months of age. According to current pediatric immunization guidelines, infants aged 6 to 11 months who are traveling internationally to highly endemic areas should receive one dose of the MMR vaccine and one dose of the hepatitis A vaccine prior to departure. However, because circulating maternal antibodies can blunt the infant's immune response, doses administered before 12 months of age do not provide reliable long-term immunity and do not count toward the routine pediatric immunization series. Furthermore, the infant's mild upper respiratory infection is a false contraindication to vaccination, and his developmental milestones (rolling, tripod sitting) are perfectly normal for his corrected gestational age of 6 months.

Step-by-Step Solution

1
Evaluate the patient's travel risk and age-based vaccine indications.
The patient is 8 months old and traveling to a highly endemic area for measles and hepatitis A.
Infants aged 6 to 11 months are at high risk for severe complications from measles and hepatitis A during international travel, prompting specific early vaccination protocols.
2
Determine if the early vaccine doses will count toward the standard pediatric series.
Doses given before 12 months of age do not count toward the routine series.
Circulating maternal IgG antibodies in infants under 12 months can neutralize the vaccine antigens, preventing the formation of a robust, long-lasting memory B-cell response.
3
Assess the patient's developmental milestones based on his prematurity.
Chronological age is 8 months; corrected age is 6 months (born at 32 weeks). Tripod sitting is a normal 6-month milestone.
Premature infants are assessed for developmental milestones based on their corrected gestational age to avoid false diagnoses of developmental delay.
4
Assess the patient's current mild illness as a potential vaccine contraindication.
The patient has a mild viral upper respiratory infection, which is a false contraindication.
Mild acute illnesses, with or without low-grade fever, do not significantly impair the immune response to vaccines or increase the risk of adverse vaccine reactions.

Key Concept

Immunization management for international travel in premature infants
Estimated Time:2m 0s
PreviousPage 118 / 414Next